NM_005629.4:c.283G>A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
This summary comes from the ClinGen Evidence Repository: The NM_005629.4:c.283G>A variant in SLC6A8 is a missense variant predicted to cause a substitution of a valine by an isoleucine at amino acid position 95 (p.Val95Ile). This variant has not been reported in the published literature in individuals with creatine transporter deficiency. In gnomAD v2.1.1, the highest population minor allele frequency is 0.00005 (4/78678 alleles, 2 hemizygotes) in the European (Non-Finnish) population, which is greater than the ClinGen CCDS VCEP’s threshold for PM2_Supporting (<0.00002) but less than the ClinGen CCDS VCEP’s threshold for BS1 (>0.0002), such that neither of these criteria are met. The computational predictor REVEL gives a score of 0.644, which is less than the ClinGen CCDS VCEP’s threshold for PP3 (>0.75) but greater than the ClinGen CCDS VCEP’s threshold for BP4 (<0.2), such that neither of these criteria are met. There is a ClinVar entry for this variant (Variation ID: 449185, one-star review status), with conflicting interpretations of pathogenicity (one submitter: uncertain significance; two submitters: likely benign). In summary, this variant meets criteria to be classified as a variant of uncertain significance for creatine transporter deficiency. SLC6A8-specific criteria applied, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): no criteria met.(Classification approved by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel on November 8, 2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA10549177/MONDO:0010305/027
Frequency
Consequence
NM_005629.4 missense
Scores
Clinical Significance
Conservation
Publications
- creatine transporter deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005629.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC6A8 | MANE Select | c.283G>A | p.Val95Ile | missense | Exon 2 of 13 | NP_005620.1 | P48029-1 | ||
| SLC6A8 | c.283G>A | p.Val95Ile | missense | Exon 2 of 13 | NP_001136277.1 | ||||
| SLC6A8 | c.-63G>A | 5_prime_UTR | Exon 2 of 13 | NP_001136278.1 | P48029-4 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC6A8 | TSL:1 MANE Select | c.283G>A | p.Val95Ile | missense | Exon 2 of 13 | ENSP00000253122.5 | P48029-1 | ||
| SLC6A8 | c.283G>A | p.Val95Ile | missense | Exon 2 of 13 | ENSP00000625834.1 | ||||
| SLC6A8 | c.283G>A | p.Val95Ile | missense | Exon 2 of 13 | ENSP00000592689.1 |
Frequencies
GnomAD3 genomes AF: 0.0000354 AC: 4AN: 112846Hom.: 0 Cov.: 24 show subpopulations
GnomAD2 exomes AF: 0.0000189 AC: 3AN: 158720 AF XY: 0.0000201 show subpopulations
GnomAD4 exome AF: 0.0000175 AC: 19AN: 1086592Hom.: 0 Cov.: 30 AF XY: 0.0000225 AC XY: 8AN XY: 355054 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000354 AC: 4AN: 112846Hom.: 0 Cov.: 24 AF XY: 0.0000571 AC XY: 2AN XY: 35006 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at